BioSpace News Archive

PROCEPT® BioRobotics Corporation announced it will host an in-person investor event on Friday, April 28, 2023, in Chicago at the American Urological Association Annual Meeting from 8:00am to 9:30am Central Time.

Stryker announced that it will report financial results for first quarter of fiscal year 2023 on Monday, May 1, 2023.

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a developer of Next Generation Chemotherapy drugs that provide a better safety-efficacy profile than their widely used FDA-approved counterparts, today provided an update on their clinical programs and announced financial results for the year ended December 31, 2022.

Eyenovia, Inc. (Nasdaq: EYEN) today announced its financial and operating results for the fourth quarter and full-year ended December 31, 2022.

Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2022.

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, provides a business update and reports financial results for the three and twelve months ended December 31, 2022.

Surgalign Holdings, Inc. reported operating results for its fourth quarter and full year 2022 ending December 31, 2022.

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today reported financial results for the fourth quarter and full year 2022.

Aprea Therapeutics, Inc. reported financial results for the three months and year ended December 31, 2022 and provided a business update.

Edgewise Therapeutics, Inc., (Nasdaq: EWTX) today announced the publication of the article, “Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy,” in the Journal of Clinical Investigation.